Lupin Pharmaceuticals
-
Lupin bags FDA approval for SOLOSEC
SOLOSEC is used in adolescents for both the treatment of bacterial vaginosis in females and trichomoniasis Lupin Pharmaceuticals announced that…
Read More » -
Lupin gets US FDA nod for SOLOSEC
SOLOSEC is the first and only single-dose oral prescription antimicrobial agent to treat trichomoniasis Lupin Pharmaceuticals, the US-based wholly-owned subsidiary…
Read More » -
Lupin announces FDA filing acceptance of supplemental drug application for Solosec
The drug if approved could be the only single-dose oral prescription treatment for both BV and trichomoniasis Lupin Pharmaceuticals, the…
Read More »